+ Watch TEVA
on My Watchlist
A global pharmaceutical company, Teva develops, produces, and markets generic drugs covering all major treatment categories.
Yield 2.46%. DGR 18%. PE 11. Normal PE 19. EPS Growth 21%. 13 year Dividend Contender. Undervalued. Position held in Brokerage account. Reinvesting dividends. Intend to increase position using cash dividend payouts from other stocks and new investment funds.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions